Search Results

Filter
  • 1-10 of  525 results for ""Rimonabant""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile.

  • Authors : Cohen Y; Corbus Pharmaceuticals Holdings Inc., Norwood, Massachusetts, USA.; Kolodziej A

Subjects: Rimonabant* ; United States Food and Drug Administration* ; Anti-Obesity Agents*/Anti-Obesity Agents*/Anti-Obesity Agents*/adverse effects

  • Source: Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2024 Jul; Vol. 32 (7), pp. 1235-1244. Date of Electronic Publication: 2024 Jun 17.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101264860 Publication Model: Print-Electronic

Record details

×
Periodical

Rimonabant is minimally effective for weight loss.

  • Source: American Family Physician. 2006, Vol. 73, Issue 11, pages. 2018

Record details

×
Academic Journal

Rimonabant can reduce weight in type 2 diabetics.

  • Source: Medical Economics. 2006, Vol. 83, Issue 22, pages. 1

Record details

×
Academic Journal

Rimonabant of modest benefit in weight loss.

  • Source: Medical Economics. 2006, Vol. 83, Issue 5, pages. 1

Record details

×
Periodical

Weight loss with rimonabant.

  • Source: Patient Care. 2006, Vol. 40, Issue 5, pages. 1

Record details

×
  • 1-10 of  525 results for ""Rimonabant""